You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 256 No. 5, August 1, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (35)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Role of Angiotensin II in the Pathogenesis of Hyperdipsia in Chronic Renal Failure

Toshihide Yamamoto, MD; Masanori Shimizu, MD; Masahiro Morioka, MD; Mitsuo Kitano, MD; Hirokazu Wakabayashi, MD; Nobuyuki Aizawa, MD

JAMA. 1986;256(5):604-608.


Abstract

The relation of thirst to the renin-angiotensin system was examined in 38 patients with chronic renal failure receiving hemodialysis treatment. They were classified into three groups, ie, group 1(19 patients), no or modest thirst; group 2 (13 patients), moderate thirst; and group 3 (six patients), excessive thirst. The plasma renin activity, plasma angiotensin II levels, and interdialytic weight gains of groups 1 to 3 significantly increased in a progressive manner with intensity of thirst. The hyperdipsia experienced by four patients in group 3 ameliorated after administration of an angiotensin-converting-enzyme inhibitor. The hyperdipsia of some patients with chronic renal failure therefore appears to be mediated by increased production of endogenous angiotensin II.

(JAMA 1986;256:604-608)



Author Affiliations

From the Departments of Internal Medicine, Kishiwada Tokushukai Hospital (Drs Yamamoto and Wakabayashi), Osaka; Yamato Tokushukai Hospital (Dr Shimizu), Yamato-koriyama; Hanyu Seikyo Hospital (Dr Morioka); Yao Tokushukai Hospital (Dr Kitano); and Chigasaki Tokushukai Hospital (Dr Aizawa), Japan.


Footnotes

Presented in part at the 15th International Congress of the International Society of Psychoneuroendocrinology, Vienna, July 17, 1984.

Reprint requests to the Department of Internal Medicine, Kishiwada Tokushukai Hospital, 4-22-38 Isonokamicho, Kishiwada, Osaka 596, Japan (Dr Yamamoto).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Benefits of and Barriers to Dietary Sodium Adherence
Welch et al.
West J Nurs Res 2006;28:162-180.
ABSTRACT  

Review: The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease
Sica and Gehr
Journal of Renin-Angiotensin-Aldosterone System 2002;3:247-254.
ABSTRACT  

Advising dialysis patients to restrict fluid intake without restricting sodium intake is not based on evidence and is a waste of time
Tomson
Nephrol Dial Transplant 2001;16:1538-1542.
FULL TEXT  

Angiotensin, Thirst, and Sodium Appetite
FITZSIMONS
Physiol. Rev. 1998;78:583-686.
ABSTRACT | FULL TEXT  

Impaired Arginine-Vasopressin Secretion Associated With Hypoangiotensinemia in Hypernatremic Dehydrated Elderly Patients
Yamamoto et al.
JAMA 1988;259:1039-1042.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.